Development of Marine Antiviral Drug

Available treatments for many infectious diseases are limited. In particular, diseases caused by viral pathogens have demonstrated a need for new drugs because of increasing resistance to these existing treatments. Thousands of novel compounds have been isolated from various marine organisms and tested for their pharmacological properties, many of which are commercially available. Screening of natural products derived from marine species for antiviral activity has yielded a large number of active crude aqueous and organic solvent extracts. For example, extracts of marine microalgae exhibited inhibitory effects on the replication of hemorrhagic septicemia virus (VHSV) and African swine fever virus (ASFV) in vitro. By focusing on marine organisms, CD BioSciences aims to uncover natural compounds that exhibit potent antiviral activity and can potentially become essential therapeutics in the battle against viral infections. We strive for large-scale production of these compounds to meet the needs of clinical trials and drug development.

Our Services

Our talented team of scientists, toxicology, molecular biology, chemistry, and immunology experts fully understand that the antiviral drug development process is not the same for all methods.

• Extraction and Isolation of Marine Bioactive Compounds
  With our cutting-edge research capabilities, state-of-the-art facilities, and a world-class team of scientists, we are committed to revolutionizing the field of antiviral drug development. Our scientists isolate, purify, and characterize compounds with antiviral activity from marine organisms.
  
  • Bacteria
    Our scientists isolate bioactive compounds from bacteria, actinomycetes and cyanobacteria.
  • Algae
    Our scientists have identified microalgae and macroalgae as one source of natural compounds that have shown anti-HIV activity in vitro.
  • Sponges
    Our scientists isolate bioactive terpenes, sterols, cyclic peptides, alkaloids, fatty acids, peroxides and amino acid derivatives from sponges.
  • Fungi
    Our scientists found that compounds derived from marine fungi selectively inhibit cancer cell lines.
• Integrated Drug Discovery
  
  • Target/hit identification
  • Hit to lead
  • Lead optimization
  • Candidate id/selection
  • Commercial manufacturing
• Characterization of Marine Antiviral Compounds
  
  • Biophysical characterization
  • Physicochemical properties
  • Cell-based assays
  • Biosafety testing

Why Partner with Us?

• Comprehensive: A broad portfolio of over 2,000 assays keeps your projects ahead of the curve.
• Collaboration: Our clients work directly with our team of top scientists.
• Consistency: Full coverage of antiviral testing capabilities, including biochemical, biophysical, cell and in vivo models, to ensure data consistency within the project.
• Interdisciplinary: We work with the best partners to provide medicinal chemistry support as well as ADME-Tox and cardiac safety services.
• Customer Service: We provide continuity through a dedicated team of senior scientists.

Laboratory Instruments

CD BioSciences is a professional service provider for the marine biology industry. Our marine antiviral drug development services can ensure that the most suitable methods and techniques are selected for your project. We provide our customers with the most precise ingredient data and highly informed process expertise. Our team of biomass experts plays a key role in the formulation, optimization and commercial evaluation of biomass value-added processes in industry and academia. If necessary, please feel free to contact us.

Please kindly note that our services can only be used to support research purposes (Not for clinical use).